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Validation of subscales of the Severe Asthma 
Questionnaire (SAQ) using exploratory factor 
analysis (EFA)
Joseph W. Lanario1, Michael E. Hyland1,2* , Andrew Menzies‑Gow3, Adel H. Mansur4, James W. Dodd5, 
Stephen J. Fowler6, Rupert C. Jones1 and Matthew Masoli7
Abstract 
Background: The Severe Asthma Questionnaire (SAQ) is a health related quality of life (HRQoL) questionnaire vali‑
dated for use in severe asthma. It is scored using the mean value of 16 items (SAQ score) in addition to a single item 
global rating of HRQoL (SAQ‑global). The aim was to validate clinically relevant subscales using exploratory factor 
analysis (EFA).
Methods: The SAQ was completed, along with measures of asthma control and EQ5D‑5L by patients attending six 
UK severe asthma centres. Clinical data were included in the analysis. EFA using principal axis factoring and oblimin 
rotation was used to achieve simple structure of data.
Results: 460 patients with severe asthma participated, 65% women, mean age 51 (16–83) years. A three factor 
solution achieved best fit and showed that the SAQ items formed three distinct but inter‑correlated groups of items 
where items were grouped in a way that was consistent with item content. The three subscales were differentially 
associated with clinically relevant variables (lung function and mood). Males and females interpreted the question of 
night disturbance in different ways.
Conclusions: This paper provides a template for best practice in the use of EFA when validating HRQoL subscales. 
The SAQ can be scored as three subscales with content reflecting three different constructs people with severe 
asthma use when making judgements about their lives. The subscale ‘My Life’ assesses the impact of severe asthma 
on different life activities, ‘My Mind’ assesses the perceived emotional impact and ‘My Body’ the impact of extra‑pul‑
monary symptoms and side effects.
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Background
Validated health-related quality of life (HRQoL) ques-
tionnaires are used in clinical practice and research 
to evaluate the impact of disease and/or treatment 
responses. They consist typically of several items the 
responses to which are aggregated to form an overall 
HRQoL score. Subscales can be formed from groups of 
items as subscales provide information that can be useful 
in clinical trials and clinical practice.
Guidelines for validating questionnaires recommend a 
two stage process where content validity is followed by 
construct validity [1], but these recommendations were 
published after the publication of four asthma specific 
HRQoL questionnaires. Validation of the asthma qual-
ity of life questionnaire’s (AQLQ) subscales is based only 
on content validity [2, 3] as the subscales are formed by 
grouping items on the basis of an examination of content 
alone. However, in three other asthma specific HRQoL 
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questionnaires subscales are validated by both content 
validity and construct validity. This is done by show-
ing that items initially grouped on the basis of content 
have similar statistical properties, using either principal 
component analysis [4, 5] or principal factor analysis [6]. 
The advantage of construct validation is that it can show 
whether patients’ interpretation of the meaning of items 
is the same as that of the researchers.
The number of subscales in existing asthma specific 
HRQoL varies between three [5], four [2], five [6] and 
six [4], but despite this variation, there is consensus that 
activity restriction and mood should be measured in dif-
ferent subscales. Activity-related items are assessed in 
subscales labelled ‘activity limitation’ [2], ‘activity’ [5], 
and ‘activities’ and ‘avoidance’ [6]. Items relating to the 
emotional impact of asthma are assessed in subscales 
labelled ‘emotional function’ [2], ‘mood’ [4] and ‘distress’ 
and ‘preoccupation’ [6].
The Severe Asthma Questionnaire (SAQ) is the only 
validated HRQoL questionnaire for specifically severe 
asthma [7]. It comprises 16 inter-correlated items meas-
uring the impact of disease and medical interventions, 
and the mean of those items forms the SAQ score [8]. In 
addition, the questionnaire has a single question meas-
uring the impact of disease and its treatment on the 
patient’s overall perception of quality of life, the SAQ-
global score. Content validity for the questionnaire was 
established in two qualitative studies [7, 9], and construct 
validity for the SAQ score demonstrated by factor analy-
sis. The content of the16 items fall into three categories. 
Items 1–7 ask patients to rate the impact of their asthma 
and its treatment on seven different types of life activ-
ity, and have content consistent with items in the activ-
ity subscales of earlier questionnaires. Items 8–11 ask 
patients about various aspect of mood and have content 
consistent with that in the emotional subscales of earlier 
questionnaires. Items 12–16 assess the impact on life of 
extra-pulmonary symptoms and side effects. These last 
five items measure quality of life deficits that are typically 
found only in severe asthma where qualitative research 
shows them to play a major role [7, 9–11]. They are rare 
in mild and moderate asthma and have limited represen-
tation in earlier asthma specific HRQoL questionnaires 
[9]. Content derived subscales for the SAQ and one con-
sistent with earlier scales would therefore be based on 
three subscales (a) impact on life’s activities (b) impact 
on emotional well-being, and (c) impact of extra-pulmo-
nary symptoms including those caused by side effects of 
treatment.
Although there is a rationale for having three sub-
scales of the SAQ on the basis of content, that subscale 
structure has not been construct validated. Subscales 
of HRQoL scales are useful because they provide more 
detail about the patient’s experience, and this greater 
detail facilitates communication with the patient as well 
providing more nuanced information about HRQoL 
change in clinical trials. The aim of this study is to pro-
vide construct validation of the subscales of the 16 items 
of the SAQ by showing that the different subscales are 
associated with different constructs. In this study, con-
struct validity is achieved by providing evidence that (a) 
the 16 items fall into statistically distinct clusters; (b) that 
items in the statistically formed subscales are consistent 
with classification based on content; (c) that the subscales 
formed from these clusters have different associations 
with clinically relevant variables and therefore provide 
additional information compared to the overall scores.
Methods
Design
This was a cross-sectional study with questionnaire and 
clinic data each collected at one time point.
Participants
Patients aged ≥ 16 years of age and diagnosed with severe 
asthma as defined by the ERS/ATS guidelines were 
invited to participate [12]. Participants were recruited 
from six UK severe asthma centres and were excluded if 
they were diagnosed with another condition that signifi-
cantly contributed to their respiratory health, e.g. lung 
cancer, heart disease or chronic obstructive pulmonary 
disease.
Patient reported outcome measures
Severe Asthma Questionnaire (SAQ)
The SAQ consists of 16-items scored from 1 to 7, with a 
higher score indicating better quality of life. The mean 
of the 16 items is calculated to provide the SAQ score. 
The SAQ also contains a separate, Borg-type scale rang-
ing from 0–100 and based on the Global Quality of Life 
Questionnaire [13] which provides the SAQ-global score 
[8].
Asthma Control Test (ACT)
The ACT consists of five asthma symptom and medica-
tion use items, which are totalled to provide an indication 
of asthma control. The sum of the five items, scale-5, is 
calculated to give the ACT score, with a higher number 
indicating better asthma control [14].
Asthma Control Questionnaire‑6 (ACQ‑6)
The ACQ consists of six items, five concerning asthma 
symptoms and one on daily use of rescue bronchodila-
tor. Patients respond to these items on a 0–6 scale (0 = no 
impairment, 6 = maximum impairment). The mean of the 
Page 3 of 10Lanario et al. Health Qual Life Outcomes          (2020) 18:336  
six items is calculated to provide the ACQ-6 score with a 
lower number indicating better asthma control [15].
EQ‑5D‑5L and mood measurement
The EQ-5D-5L consists of 5 items scored from 1 to 5 
with a higher score indicating greater impairment, and 
a 0–100 visual analogue score, the EQ-5D VAS [16]. 
Index scores are calculated using the 2012 value set for 
England [17] and these index scores are presented here. 
For this study we used item 5 of the questionnaire as a 
proxy measure of mood. Participants indicate the degree 
to which they feel “anxious or depressed” on a five point 
scale of severity.
Clinical data
Clinical data included body mass index (BMI) and 
asthma severity as measured by the following items: 
GINA treatment step, spirometry (forced expiratory 
volume in 1  s  (FEV1) and  FEV1% predicted), predniso-
lone dose (mg/day), health care utilisation in the last 
12  months including number of hospital admissions, 
emergency department visits and exacerbations requir-
ing oral corticosteroids (OCS). An estimate of cumulative 
OCS exposure (mg/year) was calculated by multiplying 
a patient’s maintenance OCS dose by 365 and adding an 
estimated use of OCS following each exacerbation. Brit-
ish Thoracic Society and GINA guidelines suggest that 
40  mg of prednisolone for 7  days should be prescribed 
for the treatment of exacerbations [18]. This equates to 
280 mg of OCS per exacerbation.
Procedure
Patients with severe asthma at five specialist treatment 
centres were approached for recruitment to this study. 
Questionnaires were completed in clinic once written 
informed consented was given. Spirometry was con-
ducted either at the time of questionnaire completion or 
the most recent within the previous 6 months. Participat-
ing sites collected either ACT or ACQ data as a measure 
of asthma control for this study as per their normal clini-
cal practice. The same data collected for a previous study 
[8] from a sixth specialist centre were also included for 
analysis.
Ethical approval
This study received ethical approvals from the Research 
Ethics Committee/Health Research Authority (REC ref-
erence: 19/WA/0011, IRAS project ID: 250167) and was 
sponsored by University Hospitals Plymouth NHS Trust. 
Data from a previous study received ethical approval 
number 16/NE/0188, IRAS ID: 207601) [8].
Statistical analysis
Exploratory factor analysis (EFA) is a statistical proce-
dure that can be used to make inferences about underling 
causal structures. The procedure is based on the assump-
tion that correlations between variables is due to a com-
mon cause, referred to mathematically as a factor (i.e., 
causal factor) and psychologically as a construct (i.e., psy-
chological construct.) In the case of patient reported out-
comes, the constructs are dimensions of meaning that are 
responsible for the way patients interpret and respond to 
the individual items of a questionnaire. People can use 
many different dimensions of meaning to evaluate their 
outcomes, so the aim of the technique is to identify the 
main dimensions that drive response to individual items. 
Factor solutions that achieve a ‘simple structure’ [19, 20] 
indicate that those main dimensions have been identified 
and therefore provides a good description of the underly-
ing dimensions of meaning used to interpret the items of 
a questionnaire. However, people interpret any item of a 
questionnaire by using one or more dimensions of mean-
ing, and so discovery of the main dimensions of meaning 
is aided if the items tend to be specific to different mean-
ing dimensions. Factor analysis of patient reported out-
comes is therefore a way of exploring the meaning of a 
questionnaire but that exploration depends on the items 
of the questionnaire. The meaning of simple structure 
and the rationale for choosing the factor parameters for 
this analysis are described below.
There are two main forms of data extract: principal 
component analysis and factor analysis. Principal com-
ponent analysis is a simpler and older form of analysis 
that became popular when computers were slower and is 
the default option in many statistical packages. Principal 
component analysis is a method of data reduction only, 
it does not distinguish between unique and shared vari-
ance and therefore does not identify causal factors (psy-
chological constructs). The method risks overestimating 
variance. Factor analysis analyses only shared variance 
and in so doing provides information about underlying 
causal structures, it does not inflate estimates of vari-
ance and for most purposes is the recommended form of 
extraction [20]. We used factor analysis rather than prin-
cipal component extraction because we wanted to iden-
tify causal constructs and estimate variance, and we used 
principal axis factor analysis as a commonly used type of 
factor analysis [20].
EFA is an exploratory tool that provides choice in the 
numbers of factors to be extracted. When used for sub-
scale construction in HRQoL, the primary determinant 
of factor number and hence subscale number is a num-
ber that is both theoretically plausible and clinically use-
ful. If that number produces a simple structure (see later), 
then that number can be accepted as the final solution. 
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If that number fails to produce a simple structure, then 
alternatives should be considered. In our case, a plausible 
and useful number based on content is that there should 
be three factors, corresponding to activity, emotion and 
extra-pulmonary symptoms.
There are several driven methods of determining fac-
tor number that can be used in addition to the primary, 
theoretical determination, but these methods typically 
produce different results and are therefore advisory only 
[19]. The eigenvalue is a measure of variance explained, 
and because of the way factors are extracted eigenval-
ues decrease with the number of factors extracted. The 
default setting in many statistical packages is to select the 
number of factors with eigenvalues greater than one (the 
Kaiser–Guttman rule) [21]. Because eigenvalues increase 
with the number of items analysed this method provides 
limited information and is widely held to be the least use-
ful data driven method of advising on factor number [19, 
20]. However, the overall pattern of all eigenvalues is use-
ful not only by providing data for another, widely recom-
mended test of factor number, the scree test. The scree 
test requires inspection of the eigenvalues to determine 
the point at which eigenvalues reduce in a similar way–
the analogy is with the scree at the bottom of a cliff.
Once the number of factors is set, principal axis fac-
toring coupled with rotation provides a solution capable 
of interpretation. The technique of rotation can be done 
either by forcing the factors to be uncorrelated (called 
orthogonal rotation, e.g., varimax) or allowing the factors 
to be correlated (called oblique rotation, e.g., oblimin, 
promax), each type of orthogonal or oblique rotation 
having slightly different properties. Orthogonal rota-
tion should be used only when uncorrelated factors are 
predicted on theoretical grounds or when there is evi-
dence from an earlier oblique rotation that the factors 
are largely uncorrelated. Varimax (i.e., orthogonal) rota-
tion became popular through its use in psychology where 
there was a theoretical requirement for personality fac-
tors to be uncorrelated [22], but this form of rotation is 
often used incorrectly in  situations where factors may 
be correlated. In the present case, factors are predicted 
to be correlated as the three content derived domains of 
the SAQ all form part of the overall HRQoL. Promax and 
oblimin are commonly used forms of oblique rotation, 
promax being computationally simpler than oblimin, 
oblimin being the preferred form [20] and that which was 
used here.
EFA produces a factor matrix where each item of a 
questionnaire has a value, called a loading, on each of the 
factors. The item loadings vary between − 1 and 1 and 
can be considered equivalent to correlations between 
the item and the artificial variable represented by the 
factor. We adopted the convention that items that load 
at or greater than 0.3 should be allocated to that factor 
[19, 20]. Orthogonal rotations produce only one factor 
matrix whereas oblique (i.e., correlated) rotations pro-
duce two matrices, the structure matrix and the pattern 
matrix. The pattern matrix expresses the relationship 
between items and a factor after removing the effect of 
the correlations between the factors, and therefore pro-
vides a clearer picture of the separation of items between 
factors, should that be the case, compared to the alter-
native, the structure matrix. However, by removing the 
correlations between factors, only the factor loadings of 
the structure matrix but not of the pattern matrix can 
be considered equivalent to a correlation with an artifi-
cial variable. Therefore, in order to interpret the pattern 
matrix it is necessary to know the degree of correlation 
between the factors produced by the rotation. These fac-
tor correlations are reported separately from the pat-
tern matrix, and are similar but not identical to subscale 
correlations because factor correlations are based on 
response to weighted items whereas subscales are based 
on unweighted items [19].
Rules for sample size for EFA have largely disappeared 
because sample size depends to some extent on the data 
though a common rule of thumb is a ratio of 10:1 par-
ticipants to items [19]. Adequacy of sample size can be 
checked statistically. The solution provided by any EFA 
depends on the correlation matrix between the variables. 
Differences in that matrix resulting from low correlations 
and small sample sizes can produce large differences in 
solution, i.e., factor instability. The Kaiser–Meyer–Olkin 
measure of sampling adequacy provides a way of measur-
ing the level of factor stability. The Kaiser–Meyer–Olkin 
varies between zero and one, values above 0.8 indicating 
that the factor solution is likely to be stable, and above 0.9 
highly stable. However, if sample size allows, factor sta-
bility can be checked by separate analysis of subgroups. 
In the analysis conducted here, we examined factor solu-
tions for males and females separately, a technique that 
also checks that males and females interpret every item 
in the same way.
The aim of an EFA, as a statistical tool, it to find a solu-
tion where there is a simple structure to the data. Sim-
ple structure is summarised as “item loadings above 0.30, 
no or few item crossloadings, no factors with fewer than 
three items” [20]. Validation of HRQoL subscales has an 
additonal requirement, that the subscales so produced 
are both theoretically plausiable in terms of content as 
well as clinically useful. An EFA solution producing 10 
subscales may achieve simple structure but is unlikely to 
have much clinical use. Cross-loading items (i.e., where 
the loading is > 0.3 on more than one factor) indicate 
either that response to the item is affected by more than 
one construct, or that the solution provides a poor fit 
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for data. Either way, the presence of cross-loading items 
is undesirable and absence of all but a bare minimum of 
cross-loading items is a primary requirement for con-
struct validation of subscales of a HRQoL questionnaire 
[20]. Validation requires a “clean” factor matrix, namely 
one where there is good separation between loadings for 
every item. An item that loads 0.32 on one factor and 
0.25 on another is a poor item. Items with loadings of 
0.32 and 0.01 and 0.25 and 0.60 are acceptable, but the 
goal is for the largest possible separation.
Although a HRQoL questionnaire may fail to provide 
validated subscales according to the criteria described 
above, the overall scale score can still be used. It is almost 
inevitable that all the items of HRQoL questionnaires 
will load on the first unrotated factor. This is because, in 
general, HRQoL deficits in a population increase with 
severity and so the first factor unrotated factor is sim-
ply a severity factor. An HRQoL item must by definition 
be related to health and it would be unusual if an item 
failed to correlate with overall severity. Subscale con-
struct validation by EFA is more demanding as it requires 
specificity of items to constructs, rather than specificity 
to severity.
Following EFA, subscales were constructed on the basis 
of the factor loadings by taking the mean of items loading 
on any factor. The relationship between the subscales and 
other variables was examined using Pearson correlations. 
EFA and correlations were conducted using SPSS version 
25. Tests of difference between correlations were carried 
out using Psychometrica (https ://www.psych ometr ica.
de/corre latio n.html).
Results
The total sample size was 460 consisting of data from 160 
participants who provided data for a previous validation 
study [8] and 300 participants who provided new data. 
Two hundred and ninety-nine (65%) of the participants 
were female. Further patient demographics are shown in 
Table 1 and the mean questionnaire scores are shown in 
Table 2.
The Kaiser–Meyer–Olkin measure of sampling ade-
quacy was 0.96 for the total sample and was 0.94 for both 
the male and female subgroup analyses. For the total 
sample, the first five eigenvalues were 10.5, 1.1, 0.87, 0.64 
and 0.45. All 16 items loaded > 0.64 on the first unro-
tated factor of a principal axis factor analysis. The pattern 
matrix is shown in Table 3. The factor correlations were: 
factors 1 and 2 r = 0.70, factors 1 and 3 r = 0.73, factors 2 
and 3 r = 0.67.
Fifteen of the 16 items loaded on only one of the three 
factors with item grouping consistent with the content 
derived domains. Item 14 (night disturbance) loaded 
on two factors: factor 1 and factor 3. When EFA was 
repeated separately for males and females, then any item 
loading on a factor in the overall analysis was replicated 
in these sub-analyses, with one exception. For males 
item 14 loaded only on factor 1 (0.67) but not on factor 
3 (0.29) or 2 (− 0.10), whereas for females item 14 loaded 
on factor 1 (0.41) and on factor 3 (0.41) but not on factor 
2 (0.57). These results indicate that for the cross-loading 
item 14, males and females respond in different ways.
Table  4 shows the correlations between clinically rel-
evant variables and the three subscales created from the 
mean of items allocated to that subscale. Table 5 shows 
the correlations between all questionnaires. Together 
these two tables illustrate differences in correlations 
between subscales and theoretically relevant variables. 
Using tests of difference between correlations, the corre-
lation between  FEV1% predicted and My Life was signifi-
cantly different (p = 0.016) from the correlations between 
Table 1 Participant demographics
Sample sizes vary as a function of data availability
N Mean (CI) n (%)
Age, yrs 460 51 (50–53)
Female, n 460 299 (65)
FEV1, L 457 2.12 (2.05–2.20)
FEV1, % predicted 454 71.75 (69.79–73.71)
Caucasian, n 460 416 (91)
BMI, kg/m2 459 31.10 (30.39–31.81)
Prescribed maintenance OCS, n 460 218 (47)
Exacerbations in the last 
12 months requiring OCS, n
460 3.74 (3.35–4.12)
Emergency Department visits 460 0.91 (0.66–1.15)
Hospital visits 460 0.65 (0.43–0.87)
Cumulative prednisolone, mg/yr 460 3148 (2814–3483)
Receiving biologics, n 456 180 (39)
Table 2 Mean questionnaire scores (95% confidence 
intervals)
Sample sizes vary as a function of data availability
n Mean
SAQ score 449 3.99 (3.84–4.14)
SAQ My Life 449 4.16 (3.99–4.32)
SAQ My Mind 449 4.04 (3.87–4.21)
SAQ My Body 449 3.58 (3.43–3.73)
SAQ‑global score 452 53.88 (51.66–56.10)
ACQ score 258 2.68 (2.50–2.86)
ACT total 200 14.32 (13.49–15.14)
EQ‑5D‑5L 381 0.69 (0.67–0.72)
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 FEV1% predicted and either My Mind or My Body. The 
correlation between Anxiety/depression and My Mind 
was significantly different (p < 0.001) from the correla-
tions between Anxiety/depression and either My Life or 
My Body.
Discussion
According to current recommendations, measures of 
patient reported outcomes should be validated first by 
content validity and then by construct validity [1]. In 
the case of subscales it is possible to group items on the 
basis of content alone, and this is a feature of some of the 
earlier scales [2]. Construct validation provides an addi-
tional level of certainty by showing that there is a statisti-
cal basis for grouping items. In this study we used EFA to 
show that the 16 items of the SAQ fall into three groups, 
with all but one the items loading only on one factor, that 
one item (night disturbance) loading on two factors and 
therefore not performing according to prediction. On 
the basis of item content, of the single loading items, the 
groups of items are given the domain labels, My Life as 
the items refer to activities and other aspects of a per-
son’s life, My Mind as the items refer to self-perceptions 
of mental state and My Body as the items refer to the per-
ceived impact of extra-pulmonary symptoms including 
side effects on the body. The relationship between items 
and subscales is shown in Fig. 1.
The night disturbance item cross-loads on the My Life 
and My Body factors, but males and females interpret the 
question differently. For females, the night disturbance 
item loads equally on the My Life and My Body factors, 
showing that for females night disturbance limits daily 
activity as well as adversely affecting bodily perceptions 
(e.g., fatigue and appearance). For males, night distur-
bance loads on the My Life factor and just misses signifi-
cance on the My Body factor, indicating that for males 
the meaning of night disturbance is primarily, but not 
exclusively, in terms of limitation to daily activities. The 
night disturbance item (item 14) is scored to contribute 
to both the My Life and My Body subscales, consistent 
with the data from the total sample.
The factor structure obtained in this analysis can be 
compared to that obtained with the earlier three HRQOL 
scales for mild and moderate asthma that also used 
Table 3 Factor loadings of  the  pattern matrix 
of a principal axis factor extraction
Factor 1 Factor 2 Factor 3
My Life My Mind My Body
1. My social life 0.88 − 0.05 0.10
2. My personal life 0.85 0.10 − 0.10
3.My leisure activities 0.83 − 0.07 0.13
4. My jobs around the house 0.97 − 0.10 0.02
5. My work or education 0.76 0.05 0.07
6. My family life—how it affects me 0.84 0.15 − 0.07
7. My family life—how it affects others 0.66 0.28 − 0.03
8. Depression 0.08 0.86 0.03
9. Irritable 0.11 0.73 0.10
10. Anxiety in general − 0.06 0.94 0.05
11. Worry that asthma may get worse 0.15 0.42 0.27
12. Worry about long term side effects 
of medicines
0.04 0.18 0.52
13. Getting tired 0.23 0.115 0.56
14. Problems at night 0.47 − 0.01 0.41
15. The way I look − 0.05 − 0.00 0.89
16. Problems with food 0.10 0.10 0.64
Table 4 Correlations between different scores of the SAQ, EQ-5D-5L Index value and other variables
* p < 0.05; **p < 0.01
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component or factor analysis. Although all three scales 
provide evidence of a distinction between activity restric-
tion and emotional impact, the results are very different. 
Only one study that used oblique rotation achieved best 
fit producing five factors with minimal cross-loading 
items [6]. One using varimax rotation and produced a 
very poor fit of six factors with 28 out of 31 items cross-
loading [4]. One reported “good separation” of three 
factors but without reporting any factor loadings [5] or 
any other data. One used the scree test to determine the 
number of factors but without presenting the eigenvalues 
on which the test is based [4], one reported eigenvalues 
and, after demonstrating that the scree test could not 
be used, used pragmatic examination to give five factors 
[6], and one used three factors on the basis of content 
alone [5]. By definition all HRQoL items should correlate 
with health, and because of this items form a hierarchi-
cal structure where all items load on a first factor. In the 
present data, all items loaded > 0.6 on a first factor. The 
result is that in all HRQoL questionnaires the scree test 
is likely to indicate a one factor solution, and will do so 
long as the items are good measures of health. High load-
ings on a first principal axis factor are also a feature of 
some biomarkers because they also reflect an underlying 
dimension of health [23]. Although the scree test is rec-
ommended instead of the Kaiser–Guttman test [16] and 
is a useful statistical guide for factor number when fac-
tors are uncorrelated or weakly correlated, it cannot be 
used for determining the number of factors in the case of 
HRQoL questionnaires because of the hierarchical struc-
ture of the items. Nevertheless, whether or not a scree 
test is used, eigenvalues should always be reported, either 
to support the use of a scree test or to show that it cannot 
be used.
Despite evident weaknesses in EFA, the subscales of 
earlier asthma specific HRQoL questionnaires reflect a 
common distinction of activity versus emotions, a dis-
tinction consistent with the theory that HRQoL judge-
ments are affected by two causes [24]. One cause is the 
underlying pathology that creates disease specific symp-
toms and creates activity limitation, thereby creating the 
meaning dimension reflected in the My Life subscale. The 
other is the underlying personality of the patient which 
creates mood disturbance, thereby creating the meaning 
dimension reflected in the My Mind subscale. Similar 
activity versus emotion distinctions are found in sub-
scales are based only on content [2, 4] and in those using 
statistical analysis [4–6]. In the case of severe asthma, 
however, there is an additional group of items and mean-
ing dimension relating to the impact of non-asthma 
symptoms. These symptoms arise partly due to the poly-
symptomatic nature of severe asthma [25] and partly due 
to side effects caused by treatment such as oral corticos-
teroids. Treatment varies with severity but some patients 
experience more side effects than others. The three fac-
tor solution provides a disease specific set of subscales, 
Table 5 Correlations  (Na) between study questionnaires
** p < 0.01
a N varies due to availability of data







SAQ My Life 0.95**
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subscales that are consistent with guidelines that ques-
tionnaires and their subscales should be fit for purpose 
[1], this being something that is not achieved with five or 
six factor solutions [4, 5].
The subscales differentiate between clinically rel-
evant variables. The My Life subscale is more strongly 
related to lung function as measured by  FEV1% pre-
dicted compared to the other two subscales, and the My 
Life subscale is also more strongly related to respiratory 
symptoms as measured by the ACQ or ACT scores when 
compared to the other two subscales. Poor lung function 
creates respiratory symptoms that then adversely affects 
daily activity, so these predictions are consistent with the 
hypothesis that respiratory symptoms are a major driver 
of activity limitation. It is possible that the My Life sub-
scale is more sensitive to change in respiratory function 
in a clinical trial as activity subscales have been shown to 
be more sensitive to pharmaceutical interventions in two 
other asthma specific HRQoL scales [6, 26]. By contrast, 
the My Mind subscale is more strongly associated with 
participants’ response to a question on the severity of 
anxiety and depression compared to the other two sub-
scales. This finding would indicate that the My Mind sub-
scale may be most sensitive to change for interventions 
that affect mood. Finally, the content and statistical prop-
erties of the My Body subscale would indicate that this 
subscale may be most sensitive to changes in drug treat-
ments that alter side effects and the experience of extra-
pulmonary symptoms.
Quality of life and health are concepts used in clinical 
practice and research, but they are also words that are 
used by the general public in everyday speech. The SAQ 
asks people to evaluate the impact of asthma on ‘qual-
ity of life.’ The EQ5D asks people to rate their ‘health.’ 




My life My jobs around the house
My work or education
My family life - how it affects me
My family life - how it affects others
Overall quality of life Depression
My Mind Irritable
Anxiety in general
Worry that asthma may get worse
Worry about long term side effects of 
medicines
Getting tired
My Body Problems at night
The way I look
Problems with food
Fig. 1 Relationship between items of the SAQ and three subscales
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Examination of Table  5 shows that both types of global 
estimate correlate most strongly with the My Life sub-
scale compared to the other two subscales. When peo-
ple are asked to make global estimates of ‘quality of life’ 
or ‘health’ they interpret these words and judge them by 
preferentially using the activity limitation construct as 
measured by the My Life subscale of the SAQ.
Although construct validity is an important part of sub-
scale validation, the use of EFA for validating the over-
all score should be treated with caution. Items should 
not be selected on the basis of high factor loadings on a 
first factor as so doing can lead to overly restrictive set of 
items. Content validity through qualitative methods is an 
essential first step in establishing the items of a scale, as 
recommended by current guidelines [1]. Construct vali-
dation of subscales is carried out only after content valid-
ity is established. Although cross-loading items can be 
removed, such removal has the potential to weaken the 
breadth of the questionnaire.
A limitation of this study is that data were collected 
from only English speaking participants and not from 
participants responding to any of the validated transla-
tions of the SAQ. Those taking part were not randomly 
selected but selected by virtue of being under the care of 
a specialist severe asthma service. Estimated cumulative 
OCS dose is an estimate only. Additional longitudinal 
data collection is needed to establish the usefulness of 
subscales.
Conclusions
There are two conclusions to be drawn from this study, 
one respiratory and the other methodological. The res-
piratory conclusion is that EFA provides evidence to 
interpret the items of the SAQ as clustering into three 
meaningful subscales, subscales that are linked to three 
different types of cause affecting severe asthma. The 
three SAQ subscales measure three different constructs 
or dimensions of meaning: impact on different life activi-
ties (measured by the My Life subscale), self-perceived 
mood disturbance (measured by the Mind subscale) and 
the impact of extra-pulmonary symptoms including side 
effects (measured by the My Body subscale). The three 
subscales provide a more nuanced picture of quality of 
life deficits that can be obtained from an overall score. 
The understanding provided by this more nuanced pic-
ture should help facilitate better communication between 
patient and healthcare workers and allow more detailed 
assessment regarding response to different treatments 
and management strategies, for example, whether an 
intervention reduces lifestyle limitations, improves 
mood, or reduces side effects—or does all three.
The methodological conclusion is that best practice 
guidelines for EFA that should be adopted in preference 
to default values in statistical packages, and that con-
struct validation of HRQoL questionnaire subscales 
requires more than just running an EFA and reporting 
how items load on factors. The items of HRQoL question-
naires vary along many different dimensions of meaning. 
EFA is a way of showing the relationship between items 
and those meaning dimensions, and because of the com-
plexity of meaning, the number of dimensions or num-
ber of factors selected in the EFA can vary depending on 
the degree of granularity of meaning required. The aim of 
EFA is to find a simple structure. That simple structure 
is ‘a’ plausible solution rather than necessarily ‘the’ solu-
tion, as more than one simple structure may be achiev-
able. Guidelines for HRQoL require that the scale should 
be ‘fit for purpose’ [1] i.e., it should have a useful clinical 
role. The subscales of a HRQoL should therefore satisfy 
two constraints. First, the number and type of factors 
should be theoretically plausible and clinically relevant. 
Second the solution provided by EFA should be a sim-
ple structure where there is good separation between the 
factors. It may be that the wording of an item represents 
meaning in two or more important meaning dimensions 
(e.g., item 14 in the SAQ), and this will be represented by 
cross-loading of that item. Cross-loading items are unde-
sirable because they are poor discriminators between 
subscales. Valid subscales are made up from items that, 
with few exceptions, do not cross-load. However, an 
HRQoL scale will not have valid subscales if the only way 
to avoid cross-loading and achieve simple structure is to 
have a large number of factors with doubtful clinical use 
made up from few (less than three) items in some of the 
factors. Not all HRQoL scales will have construct valid 
subscales. This paper provides a template for future use 
of EFA for establishing validity of subscales of HRQoL 
questionnaires.
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